Drug Availability

HPS Pharmacies wish to give notice that all presentations of irbesartan and irbesartan with hydrochlorothiazide are experiencing supply issues as summarised below:

Product ARTG Expected Return Date
Avsartan 75mg 268780 Early June 2019
Avsartan 150mg 268774 Early June 2019
Avsartan 300 mg 268772 Early June 2019
Avsartan HCT 150/12.5 272655 Early June 2019
Avsartan HCT 300/12.5 272659 Early June 2019
Avsartan HCT 300/25 272662 Early June 2019

This supply interruption follows the discontinuation of a number of generic brands of irbesartan and irbesartan with hydrochlorothiazide. This has resulted in an unexpected increase in demand for the remaining brands on the market. While wholesaler stocks have been affected, HPS Pharmacies has access to a limited supply of irbesartan and irbesartan with hydrochlorothiazide for the benefit of our clients.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies

Subscribe Knowledge Centre Updates

Enter your details to receive Knowledge Centre updates